|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 199.09 USD | -3.36% |
|
-3.43% | +10.38% |
| 12-02 | BeiGene Insider Sold Shares Worth $9,190,570, According to a Recent SEC Filing | MT |
| 11-29 | Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions on site
| Capitalization | 21.89B 20.82B 19.4B 17.29B 30.79B 1,854B 33.8B 241B 89.41B 760B 82.24B 80.4B 3,273B | P/E ratio 2024 * |
-37x | P/E ratio 2025 * | -517x |
|---|---|---|---|---|---|
| Enterprise value | 20.09B 19.11B 17.81B 15.87B 28.27B 1,702B 31.03B 221B 82.08B 698B 75.5B 73.81B 3,004B | EV / Sales 2024 * |
5.4x | EV / Sales 2025 * | 4.32x |
| Free-Float |
96.17% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: BeiGene, Ltd.
More recommendations
More press releases
More news
| 1 day | +0.13% | ||
| 1 week | +7.24% | ||
| Current month | -4.18% | ||
| 1 month | +0.88% | ||
| 3 months | +9.43% | ||
| 6 months | +40.87% | ||
| Current year | +14.22% |
1 week
200.00
216.73
1 month
184.49216.73
Current year
126.97248.16
1 year
126.97248.16
3 years
118.18325.45
5 years
118.18426.56
10 years
22.51426.56
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 56 | 27/10/2010 |
Xiao Bin Wu
PSD | President | 62 | 31/03/2018 |
| Chief Tech/Sci/R&D Officer | - | 31/07/2021 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 56 | 26/01/2016 |
Michael Goller
BRD | Director/Board Member | 49 | 31/03/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 50 | 30/09/2014 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.48% | 4 M€ | -27.92% | ||
| 1.49% | 0 M€ | 0.00% | - | |
| 1.39% | 9 M€ | -4.31% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.13% | +7.24% | +9.88% | -34.42% | 21.89B | ||
| -1.88% | -2.16% | +30.13% | +124.21% | 118B | ||
| -1.68% | -0.46% | -8.01% | +18.01% | 80.65B | ||
| -1.63% | -0.62% | +37.38% | +132.17% | 37.33B | ||
| -1.37% | -2.49% | +16.29% | -66.40% | 27.71B | ||
| +2.15% | +6.78% | -36.96% | -63.10% | 20.55B | ||
| +0.62% | +3.43% | -29.92% | -36.56% | 13.7B | ||
| -3.89% | -7.45% | +734.27% | +255.40% | 13.1B | ||
| +0.01% | -4.29% | +173.11% | +179.76% | 12.96B | ||
| -0.36% | -1.93% | +7.10% | +57.43% | 12.7B | ||
| Average | -0.55% | +0.25% | +93.33% | +56.65% | 35.83B | |
| Weighted average by Cap. | -0.50% | +0.11% | +43.96% | +64.25% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 3.72B 3.54B 3.3B 2.94B 5.23B 315B 5.75B 41B 15.2B 129B 13.98B 13.67B 556B | 4.65B 4.42B 4.12B 3.67B 6.54B 394B 7.18B 51.23B 18.99B 162B 17.47B 17.08B 695B |
| Net income | -602M -573M -533M -475M -847M -50.98B -929M -6.63B -2.46B -20.91B -2.26B -2.21B -89.98B | -78.89M -75.05M -69.9M -62.31M -111M -6.68B -122M -869M -322M -2.74B -296M -290M -11.8B |
| Net Debt | -1.79B -1.71B -1.59B -1.42B -2.52B -152B -2.77B -19.77B -7.33B -62.33B -6.74B -6.59B -268B | -1.82B -1.73B -1.61B -1.43B -2.55B -154B -2.8B -20.01B -7.42B -63.08B -6.82B -6.67B -272B |
More financial data
* Estimated data
Employees
10,600
Calendar
05/12/2024
- Citi Global Healthcare Conference
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/12/24 | 199.09 $ | -3.36% | 339,746 |
| 03/12/24 | 206.01 $ | +0.13% | 395,221 |
| 02/12/24 | 205.75 $ | -4.30% | 2,095,602 |
| 29/11/24 | 215.00 $ | +4.29% | 258,633 |
| 27/11/24 | 206.16 $ | +7.31% | 341,342 |
Delayed Quote Nasdaq, December 03, 2024 at 09:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
206.01USD
Average target price
279.75USD
Spread / Average Target
+35.79%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BGNE Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition